REQUEST A DEMO
Total
USD $0.00
Search more companies

Hs Biotechnology Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Electronic Shopping and Mail-Order Houses
Full name: Hs Biotechnology Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Hs Biotechnology Sdn. Bhd. is an enterprise in Malaysia, with the main office in Shah Alam. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on December 10, 2018. The company’s latest financial report indicates a net sales revenue increase of 44.89% in 2022. Its’ total assets recorded a growth of 81.35%. In 2022, Hs Biotechnology Sdn. Bhd.’s net profit margin increased by 3.07%.

Headquarters
33-Gf, Jalan Setia Perdana Be, U13/Be,Bandar Setia Alam
Shah Alam; Selangor; Postal Code: 40170

Contact Details: Purchase the Hs Biotechnology Sdn. Bhd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Hs Biotechnology Sdn. Bhd. report to view the information.
Incorporation Date:
December 10, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hs Biotechnology Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
44.89%
Total operating revenue
44.89%
Operating profit (EBIT)
1219.42%
EBITDA
1122.12%
Net Profit (Loss) for the Period
1439.25%
Total Assets
81.35%
Total Equity
-3.33%
Operating Profit Margin (ROS)
3.72%
Net Profit Margin
3.07%
Return on Equity (ROE)
39.66%
Quick Ratio
-0.8%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?